首页> 外国专利> DIAGNOSTIC MARKER FOR SENSITIVITY TO ANTI-CANCER DRUGS AND PROGNOSIS OF CANCER

DIAGNOSTIC MARKER FOR SENSITIVITY TO ANTI-CANCER DRUGS AND PROGNOSIS OF CANCER

机译:诊断抗癌药的标志物和癌症的预后

摘要

PROBLEM TO BE SOLVED: To provide a marker adaptable to many different types of cancer or a prognosis of cancer and/or a marker capable of evaluating therapeutic sensitivity, and a method for determining prognosis of cancer and/or therapeutic sensitivity by using such a marker.SOLUTION: A method for determining the effectiveness of a given anti-cancer drug against cancer affecting a subject comprises a step of measuring the expression level of nucleolus stress response controlling protein or of genes coding such protein in a subject-derived sample and, if the expression level of the protein or genes is high in comparison with its reference value, a step of determining that the anti-cancer drug tested is highly effective against cancer, or a method may be intended for determining the prognosis of cancer after chemical treatment of the subject.SELECTED DRAWING: Figure 3
机译:要解决的问题:提供适用于许多不同类型的癌症或癌症预后的标志物和/或能够评估治疗敏感性的标志物,以及通过使用这种标志物确定癌症预后和/或治疗敏感性的方法解决方案:一种确定给定抗癌药物对影响受试者癌症的有效性的方法,该方法包括以下步骤:测量受试者衍生样品中核仁应激反应控制蛋白或编码此类蛋白的基因的表达水平,如果有,蛋白质或基因的表达水平与其参考值相比较高,确定所测试的抗癌药物对癌症高度有效的步骤,或者可能用于确定经化学疗法治疗后癌症的预后的方法主题选择。图3

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号